$2.62
0.01[0.38%]
At close: Apr 26
$2.62
0[0.00%]
After Hours: 4:32PM EDT
BioXcel Therapeutics
(NASDAQ:BTAI)BioXcel Therapeutics Stock (NASDAQ:BTAI), Insider Trading Activity
BioXcel Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
174.854K
Insider Percentage Owned
0.57%
Institutional Shares Held
7.527M
Institutional Percentage Held
24.6%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08, 2024 | Vincent O'Neill | SEE REMARKS | 2.606K | $2.62 | -$432.48 | SELL-OPTIONS | 93.00% | 5.408K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Vimal Mehta | CEO AND PRESIDENT | 11.342K | $2.62 | -$13.82K | SELL-OPTIONS | 0.13% | 8.590314M | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 1.702K | $2.63 | -$2.82K | SELL-OPTIONS | 55.57% | 4.765K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Matthew T Wiley | CHIEF COMMERCIAL OFFICER | 1.992K | $2.64 | -$2.66K | SELL-OPTIONS | 199.20% | 2.992K | Mar 15 - Apr 04 | View |
| Apr 08, 2024 | Javier Rodriguez | SEE REMARKS | 1.759K | $2.64 | -$2.67K | SELL-OPTIONS | 29.75% | 7.672K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 1.704K | $2.63 | -$2.81K | SELL-OPTIONS | 15.41% | 12.763K | Mar 14 - Apr 04 | View |
| Jun 16, 2023 | Vimal Mehta | CEO AND PRESIDENT | 2.609K | $10.64 | -$1.23M | SELL-OPTIONS | 6.64% | 41.903K | Jun 14 - Jun 16 | View |
| May 24, 2023 | Vimal Mehta | CEO AND PRESIDENT | -6.5K | $25.79 | -$167.64K | SELL | -14.19% | 39.294K | May 22 | View |
| May 16, 2023 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 0 | $27.17 | -$135.86K | SELL-OPTIONS | 0.00% | 1.5K | May 14 - May 15 | View |
| May 16, 2023 | Javier Rodriguez | SEE REMARKS | 3.215K | $27.32 | -$48.76K | SELL-OPTIONS | 283.26% | 4.35K | May 14 - May 15 | View |
| Apr 10, 2023 | Krishnan Nandabalan | DIRECTOR | 0 | $8.87 | -$1.01M | SELL-OPTIONS | 0.00% | 8.54675M | Apr 06 | View |
| Mar 22, 2023 | Vimal Mehta | CEO AND PRESIDENT | -4.5K | $9.69 | -$1.20M | SELL | -20.09% | 17.894K | Mar 20 - Mar 21 | View |
| Mar 16, 2023 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 0 | $19.50 | -$40.64K | SELL-OPTIONS | 0.00% | 1.5K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 1.099K | $19.69 | -$19.40K | SELL-OPTIONS | 13.09% | 9.496K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 1.239K | $19.70 | -$16.64K | SELL-OPTIONS | ∞ | 1.239K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Javier Rodriguez | SEE REMARKS | 1.134K | $19.63 | -$18.64K | SELL-OPTIONS | 113400.00% | 1.135K | Mar 14 - Mar 15 | View |
| Jan 24, 2023 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | -50K | $30.00 | -$1.50M | SELL | -85.62% | 8.397K | Jan 20 | View |
| Jan 24, 2023 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 0 | $15.21 | -$879.21K | SELL-OPTIONS | 0.00% | 0 | Jan 20 | View |
| Jan 06, 2023 | Krishnan Nandabalan | DIRECTOR | 0 | $11.21 | -$1.30M | SELL-OPTIONS | 0.00% | 8.54675M | Jan 04 - Jan 05 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.